| Literature DB >> 20625407 |
S A de Alencar1, Julio C D Lopes.
Abstract
Insulin-like growth factor 1 receptor (IGF1R) acts as a critical mediator of cell proliferation and survival. Many single nucleotide polymorphisms (SNPs) found in the IGF1R gene have been associated with various diseases, including both breast and prostate cancer. The genetics of these diseases could be better understood by knowing the functions of these SNPs. In this study, we performed a comprehensive analysis of the functional and structural impact of all known SNPs in this gene using publicly available computational prediction tools. Out of a total of 2412 SNPs in IGF1R retrieved from dbSNP, we found 32 nsSNPs, 58 sSNPs, 83 mRNA 3' UTR SNPs, and 2225 intronic SNPs. Among the nsSNPs, a total of six missense nsSNPs were found to be damaging by both a sequence homology-based tool (SIFT) and a structural homology-based method (PolyPhen), and one nonsense nsSNP was found. Further, we modeled mutant proteins and compared the total energy values with the native IGF1R protein, and showed that a mutation from arginine to cysteine at position 1216 (rs61740868) on the surface of the protein caused the greatest impact on stability. Also, the FASTSNP tool suggested that 31 sSNPs and 3 intronic SNPs might affect splicing regulation. Based on our investigation, we report potential candidate SNPs for future studies on IGF1R mutations.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20625407 PMCID: PMC2896858 DOI: 10.1155/2010/715139
Source DB: PubMed Journal: J Biomed Biotechnol ISSN: 1110-7243
Figure 1Distribution of IGF1R non-synonymous SNPs (nsSNPs), synonymous SNPs (sSNPs), 3′ UTR SNPs, and intronic SNPs.
List of nsSNPs that were analysed by SIFT and PolyPhen.
| dbSNP ID | Alleles | AA change | Tolerance index | PSIC | Heterozygosity | Validation |
|---|---|---|---|---|---|---|
| rs70958401 | C/T | Arg/Trp | 0.18 | 0.039 | ||
| rs70958396 | G/A | Ala/Thr | 0.41 | 0.011 | 0.039 | |
| rs61740877 | G/A | Val/Ile | 0.77 | 0.019 | n/a | |
| rs61740868 | C/T | Arg/Cys | n/a | 1 | ||
| rs61731172 | G/A | Arg/Gln | 0.74 | 0.137 | n/a | |
| rs56248469 | G/A | Arg/His | 0.57 | 0.613 | n/a | |
| rs45611935 | A/G | Asn/Ser | 0.77 | 0.387 | n/a | |
| rs45597432 | T/C | Ile/Thr | 0.96 | 0.079 | n/a | |
| rs45578132 | T/C | Val/Ala | n/a | |||
| rs45553041 | G/A | Arg/His | 0.012 | |||
| rs45526336 | G/A | Glu/Lys | 1.470 | n/a | ||
| rs45524940 | A/G | Thr/Ala | n/a | |||
| rs45522834 | C/T | Thr/Ile | 0.29 | 1.220 | n/a | |
| rs45512296 | G/A | Arg/His | n/a | |||
| rs45504297 | T/C | Leu/Pro | n/a | |||
| rs45493995 | G/T | Ser/Ile | 0.30 | 0.400 | n/a | |
| rs45475702 | G/A | Val/Ile | 0.55 | 0.296 | n/a | |
| rs45451896 | G/T | Arg/Leu | 0.25 | 0.305 | n/a | |
| rs45445894 | G/A | Val/Met | 0.947 | 0.011 | ||
| rs35224135 | G/A | Ala/Thr | 0.31 | 1.026 | 0.005 | 2 |
| rs34516635 | G/A | Arg/His | 1.00 | 1.339 | 0.005 | 1; 2 |
| rs34102392 | G/A | Ala/Thr | 0.17 | 1.097 | n/a | |
| rs34061581 | A/G | His/Arg | 0.25 | 1.346 | 0.005 | 2 |
| rs33958176 | G/A | Arg/Gln | 0.59 | n/a | 1; 2 |
Prediction scores found to be functionally significant by SIFT and PolyPhen are shown in bold.Validation Status Description: (1) validated by multiple, independent submissions to the refSNP cluster; (2) validated by frequency or genotype data: minor alleles observed in at least two chromosomes.
List of SNPs predicted to be functionally significant by FASTSNP.
| dbSNP ID | Nucleotide change | Region | Level of risk | Possible functional effect | Heterozygosity | Validation |
|---|---|---|---|---|---|---|
| rs45437300 | A/T | coding | Very High-Very High (5-5) | Nonsense | n/a | |
| rs55895813 | A/G | intronic | Medium-High (3-4) | Splicing site | n/a | |
| rs36108138 | A/C | intronic | Medium-High (3-4) | Splicing site | n/a | |
| rs45495500 | C/T | intronic | Medium-High (3-4) | Splicing site | n/a | |
| rs34226328 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.006 | 2 |
| rs35041862 | C/G | coding | Low-Medium (2-3) | Splicing regulation | 0.017 | 2 |
| rs55770488 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs35385418 | A/G | coding | Low-Medium (2-3) | Splicing regulation | 0.022 | 1; 2 |
| rs45504194 | A/G | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs45582234 | G/T | coding | Low-Medium (2-3) | Splicing regulation | 0.012 | |
| rs17847210 | G/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | 1 |
| rs56013396 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs35171849 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.011 | 1; 2 |
| rs35812156 | A/C | coding | Low-Medium (2-3) | Splicing regulation | n/a | 1 |
| rs55954954 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs45506098 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.013 | 1; 4; 5 |
| rs45598332 | G/T | coding | Low-Medium (2-3) | Splicing regulation | 0.013 | |
| rs45615734 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs45486504 | C/G | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs3743262 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.255 | 1; 4; 5 |
| rs45627636 | A/G | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs45443393 | A/G | coding | Low-Medium (2-3) | Splicing regulation | 0.011 | |
| rs45459793 | A/G | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs56400113 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs35449468 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.006 | 1 |
| rs17847208 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.005 | 1; 2 |
| rs2229765 | A/G | coding | Low-Medium (2-3) | Splicing regulation | 0.458 | 1; 2; 3; 4 |
| rs28664854 | A/G | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs35362396 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.005 | |
| rs45598038 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | 1 |
| rs34364279 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.006 | |
| rs45468291 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs56020698 | C/T | coding | Low-Medium (2-3) | Splicing regulation | n/a | |
| rs17847203 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.170 | 1; 2 |
| rs45453791 | C/T | coding | Low-Medium (2-3) | Splicing regulation | 0.039 | 1 |
Validation Status Description: (1) Validated by multiple, independent submissions to the refSNP cluster; (2) Validated by frequency or genotype data: minor alleles observed in at least two chromosomes; (3) All alleles have been observed in at least two chromosomes apiece; (4) Genotyped by HapMap project; (5) SNP has been sequenced in 1000 Genome project.
RMSD and total energy of native structure (2jo9) and mutant modeled structures.
| dbSNP ID | Amino Acid change | RMSD between native and mutant structures | Total energy after minimization (KJ/mol) |
|---|---|---|---|
| rs61740868 | Arg1216Cys | 0,48 | −13343.28 |
| rs45526336 | Glu1253Lys | 0,38 | −13887.05 |
| rs45512296 | Arg1216His | 0,46 | −13483.34 |
| rs45504297 | Leu1211Pro | 0,22 | −13782.33 |
Total energy of native structure (2jo9) after energy minimization: −13841.67.
Figure 2(a) Native structure (2jo9) showing arginine at position 1216. (b) Mutant modeled structure (2jo9 R1216C) showing cysteine residue at position 1216. (c) Superimposed structure of native structure (2jo9) (green) with mutant modeled structure (2jo9 R1216C) (gray).